Major cardiovascular adverse events in Fabry disease patients receiving agalsidase alfa.
Ferrari G, Reisin R, Kisinovsky I, Neumann P, Dragonetti L, Cáceres G, Choua M, Rozenfeld P, Marchesoni C, Finn V; Asociación Argentina de Estudio y Tratamiento de Fabry y otras Enfermedades Lisosomales (AADELFA), Fabry disease investigators.
Ferrari G, et al. Among authors: finn v.
Medicina (B Aires). 2021;81(2):173-179.
Medicina (B Aires). 2021.
PMID: 33906135
Free article.
English.